TL
The startup develops antibody-based therapeutics and provides clinical research services to facilitate the treatment of rare and incurable diseases. By offering non-clinical and clinical project management, along with orphan drug designation, the company enhances healthcare professionals' ability to deliver targeted therapies in oncology.
Updated 3 months ago
Funding
$9.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops antibody-based therapeutics and provides clinical research services to facilitate the treatment of rare and incurable diseases. By offering non-clinical and clinical project management, along with orphan drug designation, the company enhances healthcare professionals' ability to deliver targeted therapies in oncology.